Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

Clinical trial NCT07604896 · RECRUITING

Trial details

NCT number: NCT07604896
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer s Disease Alzheimer Dementia (AD)MCI-AD, Early Stage Alzheimer's Disease

Start date: 2026-01-01
Primary completion: 2027-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.